From June 16 to 19 of 2025, Boston will become the global epicenter of biotechnology as it hosts the BIO International Convention, an event that year after year strengthens its status as the most influential meeting point in the sector. This year, over 20,000 professionals from 80 countries, hundreds of startups, major pharmaceutical companies, investment funds, scientific institutions, and government agencies will gather to share knowledge, forge partnerships, and move collectively toward a smarter, more sustainable biomedical future.
Among the key players present will be i+Med, located at booth #1349 in the Spain Pavilion, representing not only technological innovation but also a unique model of cooperative scientific organization.
BIO International: More Than a Congress, a Global Platform for Opportunities
The BIO International Convention is more than a trade show, it is the world’s largest forum for business development in biotechnology. Its program features more than 135 scientific and strategic sessions, covering topics from AI in healthcare to advanced therapies like CAR-T, gene editing, oncology, rare diseases, neuroscience, sustainability, and market access.
Key highlights include:
- Corporate presentations, where startups and R&D leaders showcase their technology platforms.
- The BIO One-on-One Partnering™ system, which facilitates structured meetings with key ecosystem stakeholders.
- Dedicated areas for regulatory innovation, emerging biotech investment, and translational research.
For i+Med, participating in this event is a unique opportunity to establish strategic alliances with companies and institutions that share a forward-looking vision for the future of healthcare.
i+Med’s Technological Offering: Intelligent Systems for More Precise and Effective Biomedicine
At i+Med, we tackle modern medical challenges through an advanced technological platform based on functional nanohydrogels and personalized biopolymers, developed to meet the specific therapeutic needs of each project, active ingredient, or clinical application.
Our technology encompasses several areas of specialization:
- Nanohydrogels: Biocompatible nanoparticles capable of encapsulating active substances and releasing them in a controlled manner.
- Structured hydrogels: Polymeric matrices that function as immobilization and release systems for biomolecules, drugs, or cells, enhancing their stability and therapeutic efficacy.
- Nanocarriers: Vectorization and transport systems that deliver active compounds to specific tissues, improving bioavailability and reducing systemic exposure.
- Controlled release: Formulations designed for consistent and prolonged release, tailored to the required pharmacokinetic profile.
- Functional coatings: Biopolymers engineered to act as surfaces carrying active agents, ideal for medical devices, implants, or topical therapies.
- Phytocannabinoids: Encapsulation in water-soluble micro- and nanoparticles for pharmaceutical applications involving cannabis-derived compounds with therapeutic potential.
These technologies are geared toward collaborative design of solutions with our partners in the pharmaceutical and biotech industries, in fields such as neuroscience, ophthalmology, dermatology, and chronic inflammation.
At BIO 2025, we will showcase how these capabilities can be integrated into new developments, tech transfer projects, or therapeutic differentiation strategies.
Additionally, i+Med leads the International Institute of Intelligent Nanohydrogels from its headquarters in Álava, the first center of its kind globally, dedicated to technological transfer and cross-sector scientific collaboration.
Boston as the Meeting Point to Co-create the Future of Health
At BIO 2025, we aim to connect with partners looking to move beyond traditional approaches and collaboratively explore new methods of delivery, advanced formulation, and platforms for next-generation therapies.
From startups with breakthrough innovations to large pharmaceutical labs seeking differentiation in their pipelines, i+Med offers the technical capabilities, development flexibility, and ethical commitment of a cooperative center focused on clinically meaningful outcomes.
Want to Meet Us at BIO?
You’ll find us at booth #1349 (Spain Pavilion, ICEX).
You can schedule a meeting through the official BIO One-on-One Partnering™ platform or contact us directly at:
📩 business@imasmed.com